Clinical Trials Browser

Phase 4 × Acetylcysteine × Head & Neck × Clear all

NCT02241876 2014-09-16

THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS

Phase 4 Unknown

Head and Neck Neoplasms